journal
https://read.qxmd.com/read/38634108/experience-with-four-month-rifapentine-and-moxifloxacin-based-tuberculosis-treatment-in-san-francisco
#1
JOURNAL ARTICLE
Janice K Louie, Rocio Agraz-Lara, Gustavo E Velásquez, Allison Phillips, John D Szumowski
BACKGROUND: A multicountry randomized controlled trial has demonstrated that pan-susceptible pulmonary tuberculosis (TB) can be successfully treated with a 4-month regimen of daily isoniazid, rifapentine, moxifloxacin, and pyrazinamide (HPMZ). We piloted HPMZ in San Francisco (SF) using a modified version of the US Centers for Disease Control and Prevention HPMZ treatment guidelines. METHODS: In this retrospective cohort, patients consecutively referred to SF TB clinic were evaluated for HPMZ eligibility based on preestablished inclusion/exclusion criteria...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38628953/low-level-viremia-is-associated-with-serious-non-aids-events-in-people-with-hiv
#2
JOURNAL ARTICLE
Anuradha Ganesan, Hsing-Chuan Hsieh, Xiuping Chu, Rhonda E Colombo, Catherine Berjohn, Tahaniyat Lalani, Joseph Yabes, Christie A Joya, Jason Blaylock, Brian K Agan
BACKGROUND: The consequences of low-level viremia in people with HIV are unclear. We used data from the US Military HIV Natural History Study to examine the association of low-level viremia (LLV) and serious non-AIDS events (SNAEs). METHODS: Included participants initiated antiretroviral therapy after 1996 and had ≥3 viral loads (VLs) measured, using an assay with a lower limit of detection of <50 copies/mL, ≥6 months after antiretroviral therapy initiation...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38628952/case-series-of-people-with-hiv-on-the-long-acting-combination-of-lenacapavir-and-cabotegravir-call-for-a-trial
#3
JOURNAL ARTICLE
Monica Gandhi, Lucas Hill, Janet Grochowski, Alexander Nelson, Catherine A Koss, Francis Mayorga-Munoz, Jon Oskarsson, Mary Shiels, Ann Avery, Laura Bamford, Jillian Baron, William R Short, Corrilynn O Hileman
BACKGROUND: Injectable cabotegravir (CAB)/rilpivirine (RPV) is the only combination long-acting (LA) antiretroviral regimen approved for HIV. RPV may not be effective among individuals with non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance, which has >10% prevalence in many countries. Lenacapavir (LEN) is an LA capsid inhibitor given every 6 months, but has not been studied in combination with other LA agents. METHODS: We assembled a case series from 4 US academic medical centers where patients with adherence challenges were prescribed LEN subcutaneously every 26 weeks/CAB (+/- RPV) intramuscularly every 4 or 8 weeks...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38628951/chest-x-ray-features-of-hiv-associated-pneumocystis-pneumonia-pcp-in-adults-a-systematic-review-and-meta-analysis
#4
JOURNAL ARTICLE
Nicola K Wills, Marguerite Adriaanse, Shandri Erasmus, Sean Wasserman
BACKGROUND: The performance of chest x-ray (CXR) features for Pneumocystis pneumonia (PCP) diagnosis has been evaluated in small studies. We conducted a systematic review and meta-analysis to describe CXR changes in adults with HIV-associated laboratory-confirmed PCP, comparing these with non-PCP respiratory disease. METHODS: We searched databases for studies reporting CXR changes in people >15 years old with HIV and laboratory-confirmed PCP and those with non-PCP respiratory disease...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38628950/health-care-utilization-and-clinical-management-of-all-cause-and-norovirus-associated-acute-gastroenteritis-within-a-us-integrated-health-care-system
#5
JOURNAL ARTICLE
Jordan Cates, Claire P Mattison, Holly Groom, Judy Donald, Rebecca P Hall, Mark A Schmidt, Aron J Hall, Allison L Naleway, Sara A Mirza
BACKGROUND: Norovirus-associated acute gastroenteritis (AGE) exacts a substantial disease burden, yet the health care utilization for and clinical management of norovirus-associated AGE are not well characterized. METHODS: We describe the health care encounters and therapeutics used for patients with all-cause and norovirus-associated AGE in the Kaiser Permanente Northwest health system from 1 April 2014 through 30 September 2016. Medical encounters for patients with AGE were extracted from electronic health records, and encounters within 30 days of one another were grouped into single episodes...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38623569/epstein-barr-virus-dna-is-associated-with-conjunctival-squamous-cell-carcinomas-a-case-control-study-from-zimbabwe
#6
JOURNAL ARTICLE
Racheal S Dube Mandishora, Luisa Galati, Richard R Reich, Jean-Damien Combes, Sandrine McKay-Chopin, Rudo Makunike-Mutasa, Rangarirai Masanganise, Bevele Gwambiwa, Tricia Magombei, Francesco Alfredo Zito, Pagona Lagiou, Gary M Clifford, Anna R Giuliano, Anna E Coghill, Massimo Tommasino, Tarik Gheit
Incidence of conjunctival squamous cell carcinoma (cSCC) in Zimbabwe is >30-fold higher than the global average. cSCC risk is notably higher among people with human immunodeficiency virus, implicating impaired immune response and a yet unknown infectious etiology. Formalin-fixed, paraffin-embedded blocks from Zimbabwe, comprising conjunctival precancer (n = 78), invasive cSCC cases (n = 148) and nonmalignant eye lesions (n = 119), were tested for multiple DNA viruses using Luminex bead-based technology. Epstein-Barr virus (EBV) type 1 positivity was strongly associated with cSCC diagnosis (adjusted odds ratio [aOR], 5...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38623568/hepatitis-b-virus-prevalence-and-transmission-in-the-households-of-pregnant-women-in-kinshasa-democratic-republic-of-congo
#7
JOURNAL ARTICLE
Camille E Morgan, Patrick Ngimbi, Alix J N Boisson-Walsh, Sarah Ntambua, Jolie Matondo, Martine Tabala, Melchior Mwandagalirwa Kashamuka, Michael Emch, Jessie K Edwards, Kimberly A Powers, Linda James, Nana Mbonze, Samuel Mampunza, Marcel Yotebieng, Peyton Thompson, Jonathan B Parr
BACKGROUND: The World Health Organization Africa region has high regional hepatitis B virus (HBV) prevalence, and evidence suggests more frequent horizontal HBV transmission than other regions. Context-specific epidemiological studies are needed to inform additional HBV prevention measures. METHODS: In the cross-sectional Horizontal and Vertical Transmission of Hepatitis B (HOVER-HBV) study, we introduced HBV surface antigen (HBsAg) screening alongside existing HIV screening as part of routine antenatal care in high-volume maternity clinics in Kinshasa, Democratic Republic of Congo...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38617075/an-upsurge-of-measles-cases-in-mali-a-consequence-of-pandemic-associated-disruption-in-routine-immunization
#8
JOURNAL ARTICLE
Nginache Nampota-Nkomba, Adama Mamby Keita, Jane Juma, Diakaridia Sidibe, Nana Kourouma, Seydou Sissoko, Fadima Cheick Haidara, Cheick Tidiane Traore, Cheick Bougadari Traore, Awa Traore, Brigitte Gaume, Samba Ousmane Sow, Karen L Kotloff, Milagritos D Tapia
Measles deaths highlight immunization program gaps. In the Child Health and Mortality Prevention Surveillance study in Mali, we observed a rise in under-5 measles-related deaths in 2022 that corresponded with increased measles cases at the same time and a decline in measles vaccine coverage in Mali in 2020.
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38617074/sequential-time-to-positivity-as-a-prognostic-indicator-in-staphylococcus-aureus-bacteremia
#9
JOURNAL ARTICLE
Isin Y Comba, John Raymond Go, James Vaillant, John C O'Horo, Ryan W Stevens, Raj Palraj, Omar Abu Saleh
BACKGROUND: We aimed to determine the factors associated with sequential blood culture time to positivity (STTP) and validate the previously defined time to positivity (TTP) ratio threshold of 1.5 in predicting adverse disease outcomes and mortality of Staphylococcus aureus bacteremia (SAB). METHODS: We conducted an observational study of adult patients with SAB. The TTP ratio was calculated by dividing the TTP of the second blood culture by that of the first. RESULTS: Of 186 patients, 69 (37%) were female, with a mean age of 63...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38601746/hematological-complications-of-human-immunodeficiency-virus-hiv-infection-an-update-from-an-hiv-endemic-setting
#10
REVIEW
Jessica Opie, Estelle Verburgh, Jenique Bailly, Elizabeth Mayne, Vernon Louw
Medical professionals, particularly in regions with a high burden of human immunodeficiency virus (HIV), should be alert to the hematological complications of HIV, which may include cytopenias, malignancy, and coagulation disturbances. Patients may present with these conditions as the first manifestation of HIV infection. Hematological abnormalities are often multifactorial with opportunistic infections, drugs, malignancy, and HIV infection itself contributing to the clinical presentation, and the diagnosis should consider all these factors...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38595959/identifying-general-practitioners-antibiotic-prescribing-profiles-based-on-national-health-reimbursement-data
#11
JOURNAL ARTICLE
Pauline Arias, Matta Matta, Alessio Strazzulla, Christine Le Mener, Sébastien Gallien, Sylvain Diamantis
BACKGROUND: Antibiotic selection pressure in human medicine is a significant driver of antibiotic resistance in humans. The primary aspect of antibiotic consumption is associated with general practitioner (GP) prescriptions. We aimed to identify prescriber profiles for targeted antimicrobial stewardship programs using novel indicators. METHODS: A cross-sectional study was conducted in 2018 investigating GPs' antibiotic prescriptions in a French department, utilizing the reimbursement database of the national health service...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38595958/correction-to-oral-%C3%AE-lactams-fluoroquinolones-or-trimethoprim-sulfamethoxazole-for-definitive-treatment-of-uncomplicated-escherichia-coli-or-klebsiella-species-bacteremia-from-a-urinary-tract-source
#12
https://read.qxmd.com/read/38595957/drug-exposure-of-long-acting-cabotegravir-and-rilpivirine-in-older-people-with-human-immunodeficiency-virus-a-pharmacokinetic-modeling-study
#13
JOURNAL ARTICLE
Sara Bettonte, Mattia Berton, Felix Stader, Manuel Battegay, Catia Marzolini
BACKGROUND: The life expectancy of people with human immunodeficiency virus (PWH) has significantly increased, thanks to combined antiretrovirals with improved potency and tolerability. One further step has been achieved with the development of long-acting (LA) injectable antiretrovirals, which allow for infrequent dosing. However, the pharmacokinetics of LA antiretrovirals has been poorly characterized in older PWH, as they are generally excluded from trials. We performed virtual studies using physiologically based pharmacokinetic (PBPK) modeling to determine the anticipated exposure of LA cabotegravir/rilpivirine in older individuals...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38595956/clinical-outcomes-for-patients-with-monomicrobial-vs-polymicrobial-acinetobacter-baumannii-calcoaceticus-complex-infections-treated-with-sulbactam-durlobactam-or-colistin-a-subset-analysis-from-a-phase-3-clinical-trial
#14
JOURNAL ARTICLE
Sarah M McLeod, Alita A Miller, Khurram Rana, David Altarac, Samir H Moussa, Adam B Shapiro
BACKGROUND: In a previous study, the efficacy and safety of sulbactam-durlobactam vs colistin for the treatment of patients with carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRABC) infections were evaluated in a randomized controlled phase 3 trial. Both arms were dosed on a background of imipenem-cilastatin to treat coinfecting gram-negative pathogens. Thirty-six percent of infections in the primary efficacy population were polymicrobial. METHODS: A subset analysis was performed to compare clinical and microbiological outcomes at test of cure (7 ± 2 days after the last dose) for patients with monomicrobial and polymicrobial CRABC infections...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38595955/syphilis-treatment-systematic-review-and-meta-analysis-investigating-nonpenicillin-therapeutic-strategies
#15
JOURNAL ARTICLE
Gustavo Yano Callado, Maria Celidonio Gutfreund, Isabele Pardo, Mariana Kim Hsieh, Vivian Lin, Mindy Marie Sampson, Guillermo Rodriguez Nava, Tássia Aporta Marins, Rodrigo Octávio Deliberato, Marinês Dalla Valle Martino, Marisa Holubar, Jorge L Salinas, Alexandre R Marra
BACKGROUND: Penicillin's long-standing role as the reference standard in syphilis treatment has led to global reliance. However, this dependence presents challenges, prompting the need for alternative strategies. We performed a systematic literature review and meta-analysis to evaluate the efficacy of these alternative treatments against nonneurological syphilis. METHODS: We searched MEDLINE, the Cumulative Index to Nursing and Allied Health Literature, Embase, Cochrane, Scopus, and Web of Science from database inception to 28 August 2023, and we included studies that compared penicillin or amoxicillin monotherapy to other treatments for the management of nonneurological syphilis...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38595954/healthcare-utilization-among-infants-covered-by-medicaid-and-newly-diagnosed-with-respiratory-syncytial-virus
#16
JOURNAL ARTICLE
Mina Suh, Naimisha Movva, Xiaohui Jiang, Heidi Reichert, Susan T Pastula, Naomi C Sacks, Cara Frankenfeld, Jon P Fryzek, Eric A F Simões
BACKGROUND: Infants covered by Medicaid have higher respiratory syncytial virus (RSV) hospitalization rates than those with commercial insurance, but findings are limited to the inpatient setting. This birth cohort study describes healthcare encounters for RSV across all settings among infants covered by Medicaid and the Children's Health Insurance Program. METHODS: Medicaid claims for infants born and residing in Arizona (AZ), California (CA), Florida (FL), Michigan (MI), North Carolina (NC), New York (NY), and Texas (TX) were analyzed for first diagnosis of RSV in 2016-2018 using International Classification of Diseases, Tenth Revision codes...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38595953/-candida-spp-deep-sternal-wound-infections-a-consequence-of-antibiotic-use
#17
JOURNAL ARTICLE
Thomas McNeil, Joanna Coats, Santhosh Daniel, David Gordon
A cluster of deep sternal wound infections caused by Candida spp. occurred at our institution. Investigation did not disclose a common environmental source. We postulate that broad-spectrum antibiotic surgical prophylaxis and liberal use of antibiotics contributed to these infections.
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38595952/invasive-candida-infection-in-patients-with-bacterial-infective-endocarditis
#18
JOURNAL ARTICLE
Travis Combs, Bobbi Jo Stoner, Parker McCoy, Hassan Reda, Michael Sekela, Sami El-Dalati
Over 21 months, 12 patients with invasive Candida infections detected during the course of treatment of bacterial endocarditis, including 11 with candidemia, were identified. Invasive Candida infections can occur as a complication of bacterial endocarditis and may occur more frequently in patients with injection drug use and broad-spectrum antibiotic exposure.
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38590737/hepatitis-delta-virus-reporting-requirements-in-the-united-states-and-territories-a-systematic-review
#19
JOURNAL ARTICLE
Milaveh Assadi-Rad, Brenda E Acosta, Matthew C Hesterman, Braden S Fallon, Rachel L Hill, Ethan W Farnsworth, Bree Barbeau, Dede Vilven, Keisa M Lynch, Melodie L Weller
Hepatitis D virus (HDV) is a rare coinfection with hepatitis B virus. Currently, HDV is not a nationally notifiable disease in the United States. Only 55% of states and territories require HDV reporting, and most lack defined case definitions. Standardization of reporting requirements is crucial for monitoring HDV epidemiology.
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38585186/acute-hepatitis-due-to-primary-human-immunodeficiency-virus-infection
#20
Eric I Elliott, Daisy Smith, Jonathan Lipscomb, Bubu Banini, Lindsay Meurer, Thomas H Vanderford, Jeffrey A Johnson, Dhanpat Jain, Amit Achhra
The acute retroviral syndrome may present with diverse systemic manifestations and laboratory abnormalities. Here we present a rare case of primary human immunodeficiency virus (HIV) infection causing severe acute hepatitis. Liver histopathology demonstrated a pattern of lymphocytic inflammation consistent with acute hepatitis, high levels of HIV proviral DNA were detected within liver tissue, and immunofluorescence showed HIV p24 antigen within immune and parenchymal cells including hepatocytes. We review the literature pertaining to HIV infection of cell compartments within the liver and discuss the implications for HIV-associated acute liver disease...
April 2024: Open Forum Infectious Diseases
journal
journal
49474
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.